IMMX - CFO at Immix Biopharma Acquires Company Stock Options Worth 293000 Shares | Benzinga
Gabriel Morris, CFO at Immix Biopharma (NASDAQ:IMMX), reported a large acquisition of company stock options on November 10, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Morris, CFO at Immix Biopharma, a company in the Health Care sector, was just awarded stock options worth 293,000 shares of IMMX. The options give Morris the right to buy the company's stock at $1.86 per share.
Immix Biopharma shares are trading up 0.54% at $3.73 at the time of this writing on Friday morning. Since the current price is $3.73, this makes Morris's 293,000 shares worth $1,092,890.